Study number 8540-601
Dates
Feb 20 2025-Apr 29 2025
Location
Dallas, Texas
Age
18-60
Gender
Both
Smoker
Compensation
$21,198
Group
G1
The primary purpose of this study is to evaluate the effects of rifampin on how much the study drug gets into the blood and how long the body takes to get rid of it. Rifampin is an approved medication that is used to treat bacterial infections. In addition, the safety and tolerability of these drugs, when given both alone and together, we be evaluated. Information about any side effects that may occur will be collected.
Fortrea Dallas, TX is recruiting for:
-Healthy Males and Females of Non-Childbearing Potential, age 18-60
-Body Mass Index between 18-32
-Study involves 1 stay of 38 nights, 2 follow-up visits & 2 follow-up phone calls
-Compensation up to $21,198 may be provided for time and participation
-Refer a friend and receive $250 per qualified referral
G1:
Check-in: Feb, 20
Check-out: Mar, 30
Phone calls: Apr, 6, 21
Follow-up visits: Apr, 14, 29